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ABSTRACT
Inhibition of an RNA processing reaction after treatment
with the Ca2+- dependent micrococcal nuclease (MN)
is often used as a criterion for the presence of a
required RNA or ribonucleoprotein component in the
system. Following MN digestion, the nuclease is
inactivated with EGTA and radiolabeled substrate is
added to assay for remaining RNA processing activity.
We found previously that inhibition of RNA processing
by MN need not involve RNA hydrolysis: EGTA-
inactivated MN can suppress RNA processing if the
assay is performed in the absence of carrier RNA. We
now demonstrate both by native gel electrophoresis
and by nitrocellulose filter retention that EGTA-
inactivated MN forms a complex with free RNA which
can be dissociated by addition of synthetic
polynucleotides or heparin. In the absence of Ca2 ,
nuclease binds to precursor tRNA with an apparent
KD = 1.4 x 10-6 M, comparable to its reported affinity
for DNA. In an assay for endonucleolytic tRNA
maturation, inactivated MN bound to radiolabeled pre-
tRNA physically blocks the sites of endonuclease
cleavage and prevents tRNA processing. We call this
phenomenon 'substrate masking'. Addition of excess
carrier RNA competes with pre-tRNA for MN binding
and restores normal processing.
INTRODUCTION
Micrococcal nuclease (MN; also called S. aureus nuclease,
staphylococcal nuclease or nuclease V8) has become one of the
most thoroughly characterized enzymes (1, 2). It is a monomeric
polypeptide of 149 amino acids (1, 3) which behaves as a globular
protein in aqueous solution. It has binding sites for 3 nucleotides,
and its physical dimensions of 30 x 30 x40 A cover or protect
about 4 nucleotides of unstacked, single-stranded nucleic acid
(1). MN is a non-specific nuclease and can digest both DNA and
RNA in endo- and exo-nucleolytic fashion. The enzyme prefers
single-stranded DNA over duplex DNA (1,4,5).
MN is a metalloenzyme which requires Ca2+ for catalysis (1).
The crystal structure of an MN Ca2+ complex with the
competitive inhibitor thymidine 3',5'-bisphosphate (pdTp) has
been elucidated at 1.5A resolution (6). Site-directed mutagenesis
ofMN (2) has recently allowed separate identification of residues
involved in metal binding, in nucleic acid binding, or in catalysis.
These studies together led to a catalytic mechanism which
involves nucleophilic attack on phosphorus by a water molecule
from the second coordination sphere of Ca2 +. Ca2+ is
coordinated by Asp-21, Asp-40, the amide carbonyl of Thr-41,
two water molecules, and the oxyanion of the scissile
phosphodiester bond. This phosphodiester phosphate is also
coordinated by Arg-35, and, in the trigonal transition state, by
Arg-87 (2). The attacking water is activated by Glu-43 acting
as a general base (6).
Its broad substrate specificity and divalent cation selectivity
have made MN a useful tool for probing nucleic acid structure.
Studies on RNA processing enzymes (e.g., 7-9), and small
nuclear ribonucleoproteins (e.g., 10,11) have shown that nucleic
acid components can selectively be digested by MN treatment.
Because of its absolute ion dependence, the nuclease activity can
be inactivated by chelating agents. For investigations of
Mg2+-dependent RNA processing reactions, it is convenient to
chelate Ca2+ with ethylene glycol N,N,N',N'-tetraacetate
(EGTA) (12), whose affinity for Mg2+ is 103-fold lower than
that for other divalent cations (13). A common procedure for
testing the MN sensitivity of a suspected ribonucleoprotein
enzyme consists of two steps: a preincubation with active MN
in the presence of Ca2+ followed, after addition of EGTA, by
an assay for remaining enzyme activity. Following this protocol,
the presence of a required RNA component was inferred, for
example, in mitochondrial RNase P from HeLa cells (14) and
nuclear RNase P from veal heart (15), Sc. pombe (16), and
S. cerevisiae (17).
We previously examined the effect of MN treatment on RNA
processing activities from spinach chloroplasts (18). We found
that exhaustive MN digestion of partially purified tRNA
processing fractions completely inhibited both 5' and 3' cleavage
activities. Furthermore, and in agreement with Ryner and Manley
(19), we showed that processing activity was fully restored by
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the addition of a synthetic carrier polynucleotide (polyadenylate)
following MN treatment. Finally, we were able to demonstrate
that MN inhibition of RNA processing did not require RNA
hydrolysis because suppression of activity was equally effective
with active MN or with EGTA-inactivated MN if the enzyme
fraction tested had first been freed of endogenous RNA (18; see
below). Reversible inhibition of RNA processing by MN
treatment had previously been interpreted to indicate that the
processing enzyme(s), or the substrate * enzyme complex, was in
some way 'activated' or stabilized by bulk RNA (19). Another
hypothesis was that the enzyme fraction itself contained non-
specific RNA binding proteins which could bind added RNA
substrate to block RNA processing once endogenous RNA had
been removed with MN (W. Keller, personal communication).
We propose an alternative explanation, namely that EGTA-
inactivated MN itself is the non-specific RNA binding protein
which binds directly and with high affinity to the RNA substrate,
thus blocking access by the processing enzymes. This
phenomenon is an example of substrate occlusion or 'masking'
in which formation of an inactive enzyme substrate complex
precludes utilization of the substrate by a second enzyme. In this
communication, we have directly tested this hypothesis by using
nitrocellulose filter retention and electrophoretic retardation
analyses to measure formation of a complex between EGTA-
inactivated MN and RNA.
MATERIALS AND METHODS
Precursor RNA substrates
Precursors to transfer RNAs were transcribed in vitro from cloned
tRNA genes with phage T7 RNA polymerase as described (18).
A 200 nucleotide (nt) long 5'-mature, 3' extended precursor to
E. coli tRNAPhe was transcribed from PvuII-cut plasmid
p67CFO (a gift from Dr. 0. C. Uhlenbeck). Maize chloroplast
tRNAPhe transcripts have been described (18): pNXPhe/HindlII
transcripts are 333 nt long, whereas pNBPhe/BamHI transcripts
are 231 nt in length. A 111 nt yeast mitochondrial pre-tRNAMSP,
5'-extended and 3'-mature, was produced from BstNI-cleaved
plasmid pAsp31 ( a gift from Drs. M. J. Hollingsworth and N.
C. Martin). RNAs were labeled with one or with all four
[a32P]rNTPs to 0.072-0.84 liCi/pmol for pre-tRNAAsP and
0.165-1.24 ACi/pmol for pre-tRNAPhe.
Polymers
Polyadenylate (poly(A)), polyuridylate (poly(U)), and
polycytidylate (poly(C)) (Pharmacia, Boehringer or Calbiochem)
were dissolved in sterile water to 20- 50 mg/ml and stored at
-20°. Heparin and yeast tRNAPhe were obtained from Sigma
and stored in sterile water at - 20°C. Yeast Na-RNA was
purchased from BDH and further treated by digestion with 0.1
mg/ml proteinase K/ 10 mM Na*EDTA/ 1% SDS for 15 min
at 55°C. RNA was then extracted twice with phenol:chloroform
and precipitated twice with ethanol from 0.2M Na-acetate (pH
5.5). The final RNA pellet was dissolved at 20 mg/ml in sterile
water.
Estimation of MN Binding Sites
The number of potential micrococcal nuclease (MN) binding sites
(L) on an RNA molecule can be estimated in two ways. The size
of a single MN binding site is 4 nt (1). Since on an unoccupied
polynucleotide any tetramer is a potential binding site, the total
number of available sites (LT) on a polynucleotide N nt long is
N-4 +1 (see ref. 20). The maximum number of contiguous sites
(LC) is N14. The number of MN binding sites on a precursor
tRNA is likely to be less than that on an unstructured RNA
species, since we anticipate that MN will bind to the mature tRNA
domain (76 nt) less well than to the relatively unstructured
precursor regions. The number of contiguous single-stranded sites
(Ls) on an end-extended tRNA precursor is thus roughly
(N-76)/4. As discussed by McGhee and von Hippel (20),
however, the actual occupancy of contiguous sites will always
be less than the maximum.
For pAsp3l transcripts, LC=28 and Ls=9; for p67CFO/PvuII
RNA, Lc =50 and Ls= 31, and for pNXPhe/HindIII, Lc=83
and LS=64. For synthetic polymers we derived Lc (=Ls) from
the average Sw,20 supplied by the manufacturer. For poly(A)
(average mol wt, 112 kDa), N=323 nt, LC=81; for poly(C)
(-156 kDa), N=483 nt, LC=121; and for poly(U) (-40
kDa), N=124 nt, LC=31. We also estimated the number of
binding sites on heparin by assuming that each sulfated sugar
residue of average mol. wt. 273 (see ref. 28) binds equivalently
as does one phosphoribose group. Hence for heparin ( 14 kDa),
N=51 and Lc=13.
RNase P preparation
Fraction III spinach chloroplast processing activities were
prepared by hypotonic lysis and (NH4)2 SO4 precipitation (18),
followed by CsCl gradient centrifugation essentially as described
previously for E. coli extracts (18). An RNase P-containing
nuclear extract from Saccharomyces cerevisiae (21) was
generously provided by Greg Raymond and Jerry Johnson.
Micrococcal nuclease treatment
Micrococcal nuclease (MN) (15,000 U/mg) was purchased from
Boehringer and dissolved at 30-300 U/1d in 20 mM Hepes-KOH
(pH 8.0), 60 mM KCl, 1 mM Na EDTA (pH 8). Serial dilutions
were made in the same buffer. Preincubation of tRNA processing
enzymes was done in 5-7/A by mixing 1-2 /l of MN dilutions
(2-300 U/4l) with 1 /4l of CaCl2 (5-20 mM) or of Na EGTA
(pH 8; 50-250 mM) on ice and adding 1-4 /4l of RNase P
preparation. After 30 min at 37°C, the reaction mixture was
chilled on ice and EGTA (1 I4, as above) was added to those
reactions lacking it. Poly(A), poly(C) or carrier RNA, 10-20
ttg each, was added as indicated. The assay for remaining tRNA
processing activity was done in 20 /l final volume by adding
a substrate mix containing [32P]pre-tRNAPhe (pNXPhe/HindIH),
5% glycerol and sufficient 10x concentrated processing buffer
(200 mM Hepes-KOH [pH 8], 500 mM KCl, 150 mM MgCl2,
2 mM Na EDTA [pH 8], 20 mM DTT, and 50% glycerol) for
1 x final. The mixture was incubated 30 min at 37°C. Reactions
were terminated and analyzed by denaturing gel electrophoresis
as described (18).
Filter binding assays
Typically, one microliter ofMN (30 U//,l in 50 mM EGTA) was
added to tRNA precursor in 19 /l of 1 x processing buffer. Final
concentrations were 5.88 lsM MN and 2.5 mM EGTA. At
successive times duplicate incubation mixtures were applied with
mild vacuum to a nitrocellulose filter in a BRL Hybri-Dot-Blot
apparatus (6 mm diameter wells). Each well was then washed
twice with 200 /41 of washing buffer (processing buffer minus
DTT), dried, and exposed to X-ray film. Individual sections of
the filter were excised using the autoradiogram as a guide and
counted in toluene-based scintillation fluid. No correction was
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made for unequal counting efficiency of RNA on filters (bound
RNA) vs. input RNA in solution (total RNA).
To measure complex dissociation (Fig. 2B), a scaled up binding
reaction (as above) was incubated at 37°C for 40 minutes.
Poly(A) was added to 0.95 ,ugl4l, giving 8.5 tiM polymer. At
the indicated times after poly(A) addition, 21 Al were withdrawn
and applied to nitrocellulose filters. In the competitive dissociation
assay (Fig. 3), EGTA-treated MN was mixed with pAsp3l RNA
in processing buffer and incubated on ice for 20 min. Final
conditions were 2.35 AtM nuclease, 1.1 mM EGTA, and ca. 2
nM [32P]pre-tRNAAsP (containing 18 nM (=LS) or 55 nM
(=Lc) nuclease binding sites as described above). Serial
dilutions of poly(A), poly(U), poly(C), heparin, or yeast
tRNAPhe were made in 50 Al of water and an equal volume of
MN/pre-tRNA mixture was then dispensed into each tube of
competitor. These MN/pre-tRNA/competitor solutions were
incubated at room temperature for 20 min and the amount of
MN/RNA complex remaining was determined by nitrocellulose
filter retention (as above). The number of nuclease binding sites
on each competitor was calculated as described above.
Electrophoretic retardation assay
The electrophoretic retardation assay was performed similarly
to the protocol of Dorn et al. (22). Each reaction contained 0.36
pmol [32P]pre-tRNAPhe pNXPhe/HindIII, equivalent to 23
(=Ls) or 30 (=Lc) pmol nuclease binding sites. RNA was
incubated for 30 min at 22°C in processing buffer with 4.8 mM
EGTA and 0-1.5 U/4d (0-118 pmol total) micrococcal
nuclease. Some reactions also contained heparin (0.25-0.5,g;
equivalent to 260-520 pmol nuclease binding sites) or poly(A)
(0.25-1.0,tg; 186-740 pmol nuclease sites). After incubation,
each reaction was mixed with 5 Al of 3 x loading mix (18) lacking
urea and loaded directly onto a non-denaturing 5 %
polyacrylamide gel (acrylamide:bisacrylamide, 30:1) buffered
with 0.5 x TBE (1 x TBE is 89 mM Tris, 89 mM boric acid,
2.5 mM Na EDTA). Gels were run below 35 mA at room
temperature and analyzed by autoradiography.
Analysis of binding data
The binding experiments shown in Figure 4 were most easily
performed by titrating a fixed amount of nuclease with increasing
amounts of [32P]RNA. Unfortunately, traditional analyses of
protein- ligand interactions cannot be used to determine a
dissociation constant because multiple proteins (MN) bind to one
RNA molecule. Effectively, RNA is the 'receptor' and MN is
the 'ligand'. McGhee and von Hippel (20) have provided a lucid
treatment of the situation in which a small protein ('ligand') binds
randomly to multiple identical and overlapping sites on a linear
polymer ('one-dimensional lattice'). Application of this treatment,
however, requires that the amount of bound protein be
determined. (If the number of binding sites per polynucleotide
were constant and known, the treatment of Faus and Richardson
(23) could be applied.) Both of these models require information
which was not available. We therefore derived an exact binding
equation from the equilibrium equation which defines KD. We
are interested in dissociation of an enzyme ligand complex in
which many molecules of enzyme (micrococcal nuclease) are
bound to a single molecule of ligand (RNA). The enzyme:ligand
ratio, n, equals [MNb]/[MN -RNA]. (The subscripts b, f, and
t denote bound, free, and total species respectively.) Since
each complex contains one ligand (RNA) molecule,
[MN RNA]=[RNAb1. In the present situation, we did not
determine the efficiency of filter retention nor did we correct
for differential counting efficiency of input vs. bound RNA. We
thereforie use the superscript * for apparent values, and define
n* such that n*[RNAb]* = n[RNAb]. By substitution into the
equilibrium definition of KD, and solving for [RNAb], we derive








Values of KD * and n* were determined by direct non-linear
regression fitting of Eqn. I to the plot of [RNAb] vs. [RNAf],
using the program ENZFI'lER (R.J. Leatherbarrow; distributed
by Biosoft, Cambridge, UK). Robust weighting was used with
explicit weights (standard deviations) of 0 for each point; this
gave optimal fit to the data and was necessary for convergence
of the Marquardt iterative curve-fitting algorithm. Initial estimates
of KD* and n* were obtained within ENZFITTER using linear
regression on Eqn. II.
From the derivation of Eqn. I, it is apparent that binding
constants could also be derived from a titration of [32P]RNA
with MN. This format would have the advantage that
interpretation of side effects such as cooperativity is more
straightforward. The disadvantage is that the experiments require
considerably more mass of labeled RNA. We are interested only
in estimating KD, for which purpose the present data are
adequate.
RESULTS
Artifactual Nuclease Sensitivity of Spinach Chloroplast
RNase P
During our investigations of chloroplast transfer RNA processing,
we wished to determine whether chloroplast tRNA 5'-processing
endonuclease resembled its eubacterial counterpart, RNase P, in
possessing a required RNA subunit. We assayed pre-tRNA 5'
and 3' processing by a crude enzyme preparation after treatment
of the enzymes with micrococcal nuclease and inactivation of
the nuclease with EGTA.
Figure IA, lanes 2-4, demonstrates that chloroplast tRNA-
specific 5' and 3' endonuclease activities in a partially purified
enzyme preparation are suppressed by preincubation with
Ca2+-activated micrococcal nuclease (MN). As a control to
indicate whether the inhibition by MN resulted from hydrolysis
of specific RNA components, the MN-treated samples were
assayed in the presence of synthetic polyadenylate. Figure 1A,
lanes 5-7, shows the surprising result: tRNA processing activity
was completely restored to control levels. This enzyme fraction
had largely been freed of endogenous nucleic acids by CsCl
density gradient ultracentrifugation (see Materials and Methods).
Figure lB demonstrates that RNase P activity of this fraction
can be suppressed either by active MN or by EGTA-inactivated
MN, and that RNase P activity is restored in both instances by
addition of poly(A). Treatment of this fraction with increasing
amounts of EGTA-inactivated MN, as seen in lanes 2-4 of
Figure IA and lanes 10-12 of Figure iB, suppresses RNase
P activity and results in progressively greater electrophoretic
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Figure 2. Kinetics of interaction between pre-tRNA and EGTA-inactivated MN.
(A) Time course of association. Duplicate binding mixtures (see Methods)
containing [32P]p67CFO RNA were incubated at 22°C for the indicated times
and nitrocellulose filter retention of pre-tRNA was measured by liquid scintillation
spectrometry. (B) Dissociation ofMNfrom pre-tRNA by polyadenylate. A scaled-
up binding reaction like that of panel A was challenged with poly(A) as described
in Materials and Methods. Samples were withdrawn at the indicated times. The










Figure 1. Suppression and restoration of chloroplast transfer RNA processing
activities following micrococcal nuclease treatment. A. Restoration of activity
with poly(A). Spinach chloroplast protein (Fraction III, 1 ul) was incubated,
following Materials and Methods, in 5 ul containing 1 mM CaC12 and
micrococcal nuclease at 0, 6, 10, or 12 U/1d. Reaction was terminated with EGTA
to 5 mM. tRNA processing was then assayed in the absence (lanes 1-4) or in
the presence (lanes 5- 7) of 1 lAg poly(A)/4d. B. Both active and inactive MN
suppress RNase P activity. The enzyme source was 4 Al chloroplast Fraction Ill
activity (18), which contains little endogenous RNA. Lanes 1 and 2 are controls
for RNase P and for MN activity, respectively. Lanes 3 to 6: RNase P was
preincubated with 50 U/tl MN plus 3.3 mM CaC12 and assayed in the presence
of 12 mM EGTA and 0, 0.5, 1.6 or 2.1 j4g/4l poly(A). Lanes 7 to 15: the enzyme
fraction was treated with MN at 4.2 U/iLl (lanes 7,10,13), 6.7 UI4I (lanes 8,11,14),
or 16.7 U/4ld (lanes 9,12,15). During preincubation, MN was active (+ 3.3 mM
CaCI2) in lanes 7 to 9 and inactive (+ 11 mM EGTA) in lanes 10 to 15. RNase
P then was assayed in the absence of carrier RNA, lanes 7to 12, or in the presence
of 1 pg//sl of poly(A), lanes 13 to 15.
retardation of the [32P]RNA substrate. When poly(A) is added,
as in lanes 5-7 of Figure lA or lanes 13-15 of Figure 13,
electrophoretic retardation is relieved and RNase P activity is
restored essentially to control levels.
EGTA-Inactivated Micrococcal Nuclease Can Bind pre-tRNA
To quantify the binding of EGTA-inactivated MN to RNA, we
used a nitrocellulose filter retention assay. Labeled RNA was
Figure 3. Dissociation of pre-tRNA MN complex by various polymers. Binding
between MN and pre-tRNA was measured according to Materials and Methods.
The concentration of competitors is expressed as concentration of contiguous
binding sites (see Methods). Assays in which no competitor was present were
taken as 100% binding. An average of duplicate assays is shown.
retained on the membrane only in the presence of EGTA-treated
MN. RNA alone was not bound, nor was binding detected in
the presence of BSA, poly(A), or of heparin (data not shown).
Figure 2A shows the kinetics of complex formation between
EGTA-inactivated MN and [32P]pre-tRNA. Figure 2B
demonstrates that the complex, once formed, can be dissociated
by addition of a polynucleotide such as poly(A). The kinetics
of dissociation by poly(A) are revealing, since after an initial rapid
release they fit an exponential decay curve. This indicates that
dissociation is a stochastic process, consistent with the random,
non- specific, and primarily non-cooperative nature expected for
MN binding.
To increase our understanding ofMN -RNA interactions, we
tested a variety of polynucleotide or polyanion competitors over
a wide range of concentrations. Figure 3 illustrates that an
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Figure 4. Equilibrium binding of MN to pre-tRNA. [32P]pre-tRNAAsP bound
to MN was measured by the filter retention assay. MN (3.92 tM in 20 Al of
1.5X processing buffer and 2.5 mM EGTA) was mixed with 0.8125 nM to 32.5
nM RNA in 10 41 water. The mixture was incubated 20 min at 22°C and
MN * RNA complexes were measured by nitrocellulose filter binding. Each point
is an average of duplicate determinations. The hyperbolic curve represents the
best fit to the binding equation, Eqn. I (Materials and Methods), with
KD *=1.35 x 10-6 M and n* = 163. The inset shows a linear transformation
of the same data; the solid line is a plot of Eqn. II (Materials and Methods) using
the constants derived above.
reduction of nitrocellulose filter-bound pre-tRNA. From the
IC50 values (concentration giving 50% inhibition of binding) of
these compounds, we can rank the relative affinity of these
polymers as heparin > poly(U) > poly(C) 2 poly(A) > > yeast
tRNAPhe. Indeed, yeast tRNAPhe is unable to alleviate
suppression of RNase P activity by MN in an assay like that of
Figure lA (data not shown). This observation suggests that MN
binds poorly to mature tRNA, consistent with the finding that
MN prefers single-stranded nucleic acid as substrate (1,4).
To estimate the binding affinity of MN for RNA, we titrated
a fixed amount of MN with [32P]pre-tRNAAsP (pAsp3 1) and
determined filter-bound RNA. At the maximum, close to 75%
of the input RNA formed complexes that could be retained on
the filter. Figure 4 shows the results of a titration performed at
3.92 ytM MN and 0.8125 nM to 32.5 nM RNA. This range
corresponds to 0.007 AM to 0.29 /,tM binding sites, given that
for pAsp3l RNA, the likely number of binding sites (Ls) is 9.
The data were fitted to equation I by non-linear regression as
described in Materials and Methods, yielding an apparent
dissociation constant KD*= 1.35 x 10-6 M -0. 147 x l0-6 M.
We also calculated KD* directly from the equilibrium ratio at
each data point using the assumptions that either a 1:1 or a 10:1
protein-RNA stoichiometry or 'loading ratio' is sufficient for
filter retention. The average value so determined for KD* at
both loading ratios was 2.86 x 10-6 M + 1.06 x 10-6 M (range,
1.3 x 10-6 to 5.3 x 10-6). KD* shows little dependence on the
exact amount of MN bound to RNA, for the following reason.
The total concentration of MN in this titration is 102 to 103-fold
greater than the concentration of total RNA. The concentration
of bound MN is probably no greater than Ls, and must be less
than Lc times the concentration of bound RNA. Since Ls = 9
and Lc = 28 for pAsp3l, it follows that [MN]free = [MN]tow0
Our experimental KD* values agree well with KD determined for
metal-free MN binding to DNA of 12.8 x 10-6 M 0.5 x 10-6 M
(2). (Our binding experiments were conducted in the presence
of Mg2+, which might be expected to reduce KD. KD for pdTp
of the enzyme complex with Ca2+ or Mn2+ is lower than KD
of the enzyme alone (2)). The magnitude of KD* is consistent
with our observations of efficient but reversible binding at high
[MN], as illustrated in Figures 2 and 3.
We asked whether a protein with this KD could realistically
cause substrate occlusion or 'masking' in vitro by competing with
RNase P for pre- tRNA. KM values for eubacterial RNase Ps
are from 10-8 M to 10-7 M (24), and the apparent KD of yeast
(S. cerevisiae) nuclear RNase P for pre-tRNA is -1 x 10-9 M
(25). Thus, in our experimental nuclease treatment protocols
micrococcal nuclease successfully competes against RNase P for
binding to pre- tRNA because MN binding is driven by the high
concentration ofMN and by the high ratio of free MN to available
binding sites.
Direct Visualization of MNNRNA Complexes
Another approach to characterize protein nucleic acid binding
is detection of the complex by non-denaturing gel electrophoresis.
This method was used for the experiments shown in Figure 5.
Below an MN: binding-site ratio of - 1.5:1, a modest amount
of complex 1 (Cl) accumulates as seen in lanes 2 and 3. Lane
4 indicates that, at a ratio of -4:1, most of the pre-tRNA is
found in complex 0 which is excluded from the gel. The
remainder forms a diffuse complex C2. The amount of RNA
in the excluded complex 0 is sometimes substoichiometric, as
seen in lane 7, possibly because the complex can be lost from
the top of the gel during post-electrophoresis handling.
Figure 5, lanes 5 and 6, demonstrates that addition of excess
heparin effects essentially complete release of [32P]RNA from
the MN-RNA complexes 0 and C2. We estimated the
concentration of micrococcal nuclease binding sites in heparin
by assuming that MN could cover 4 sugar residues in heparin
just as in nucleic acids. In these experiments, the MN binding
sites in heparin were added in 8.7 or 17.3-fold molar excess over
binding sites on [32P]RNA; this represents a 2.2-fold or 4.4-fold
molar excess over molecules of MN.
We also tested poly(A) for its ability to compete for binding
MN. Figure 5, lanes 8-10, shows that molar excess of poly(A)
substantially reduces but does not eliminate the MN [32P]RNA
complex 0. The ratio of poly(A) to MN, expressed as (moles
MN binding sites):(moles MN), ranges from 1.6:1 to 6.3:1 in
lanes 8-10. This represents a 6.2 to 24.7-fold excess of binding
sites on poly(A) over sites on [32P]RNA. At the lower levels of
poly(A), the [32P]RNA migrates at a position, denoted CO in
Figure 5, somewhat slower than free RNA. This material may
represent [32P]RNA bound to only a few molecules of MN. The
relative efficiencies of heparin and poly(A) as competitors in the
gel retardation experiment of Fig. 5 are consistent with their
effectiveness measured by the nitrocellulose filter retention assay
of Fig. 3.
Nuclease Resistance of Yeast Nuclear RNase P
Having demonstrated the artifactual nature of MN inhibition of
tRNA processing in the chloroplast system, we were curious to
learn whether other reported examples of MN-sensitive RNA
processing enzymes might not also be attributable to the substrate
masking phenomenon described here. Nuclear RNase Ps from
human cells, budding yeast (Saccharomyces cerevisiae), and from
fission yeast (Schizosaccharomyces pombe) contain an RNA
subunit, as determined by biochemical purification (9,17,26). The
S. cerevisiae activity seems not to require the RNA component
for binding pre-tRNA substrate: MN treatment of a partially
purified enzyme preparation was shown not to alter the apparent
KD for RNase P pre-tRNA association (25).
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Figure 5. Electrophoretic retardation of MN-RNA complex. Incubation and
electrophoresis were as described in Materials and Methods. The positions of
MN-pre-tRNA complexes are indicated above free pre-tRNA. Lane 1 shows a
control incubation without MN. Lanes 2 to 4 contain increasing amounts of MN.
Lanes S to 9 contain the maximal amount of MN. Lanes S and 6 show complex
dissociation by increasing amounts of heparin, and lanes 7 to 9 demonstrate
dissociation by increasing amounts of poly(A). Concentrations of nuclease binding
sites were calculated according to Materials and Methods.
RNase P activity can be assayed in lysates of isolated yeast
(S. cerevisiae) nuclei (27). We treated S. cerevisiae nuclear lysate
with micrococcal nuclease, inactivated the nuclease with EGTA,
and assayed for RNase P both in the absence and in the presence
of carrier polynucleotides. Figure 6, lanes 1-3, indicates that
yeast nuclear RNase P activity is completely suppressed by
treatment with 7.5 U/4d MN when assayed without carrier RNA.
Lanes 4-6 and 10-12 of Figure 6 demonstrate that activity is
restored to control levels by addition of poly(C) to 0.625 mg/ml
or poly(A) to 0.5 mg/ml. Yeast nuclear RNase P activity thus
appears to be completely refractory to digestion by micrococcal
nuclease. We note, however, that Lee and Engelke, following
a protocol similar to that of Fig. 6, were unable to restore activity
to MN-treated samples of substantially purified S. cerevisiae
nuclear RNase P (17). The reason for this discrepancy awaits
further investigation.
DISCUSSION
Formation of RNA-MN complexes
We conclude, from the results of gel electrophoretic retardation
and of nitrocellulose filter retention experiments, that EGTA-
inactivated MN can bind RNA in a stable complex. Our results
are consistent with previous determinations that the DNA binding
domain is independent of the catalytic site (1,2,6), and that Ca2+
enhances but is not required for substrate binding (6). However,
since Ca2+, Mn2+, and Co2+ all increase binding of pdTp to
MN (6), it is possible that the Mg2+ present in our assays
likewise strengthens the interaction between MN and RNA.
The binding between ribonucleic acid and EGTA-inactivated
MN is consistent also with the substrate specificity of this enzyme.
Much of this binding is directed towards repeating anionic
substituents rather than towards specific sugars or nucleotide
bases. As shown in Figures 3 and 5, heparin, a highly sulfated
Figure 6. Apparent Inhibition of Yeast Nuclear RNase P by Micrococcal Nuclease.
Yeast nuclear extract (2 1l) was incubated with 0.75 or 7.5 U MN per IL, as
indicated below each lane. CaCl2 (2.5 mM) was present in lanes 1-6 and 13,
and EGTA (11.6 mM) was present in lanes 7-12 and 14. Following incubation
and subsequent addition of EGTA to lanes 1-6, [12P]pre-tRNAAsP was added
and RNase P cleavage was assayed. During the assay, poly(C) or poly(A), as
indicated, was present in lanes 4-6 and 10-12. Lane 13 is a positive control
for MN activity, and lme 14 is a positive control for RNase P.
mucopolysaccharide composed of derivatives of D-glucosamine
and D-uronic acids (28), can strongly displace RNA from the
MN- pre-tRNA complex. On the other hand, an uncharged
polysaccharide like glycogen, or the uncharged polymers Ficoll
and polyethylene glycol, were ineffective at displacing labeled
pre-tRNA (data not shown).
One striking suggestion of the strength of the MN RNA
interaction is seen in Figure 1B, lanes 7-12. With increasing
amounts of MN present in the reaction, there is an increasing
extent of electrophoretic retardation of the [32P]RNA substrate.
This progressive retardation is routinely observed in
electrophoresis of MN-containing reactions (18, 25, and this
work), but it is never observed in such reactions performed in
the presence of poly(A) (ref. 18, this work, and unpublished
data). It was this phenomenon which first alerted us to the
possibility that a specific MN-RNA complex might exist.
Detection of such a complex in the gels of Figure 1 is unexpected
because the reaction mixture was digested with proteinase K in
the presence of SDS and EDTA prior to electrophoretic separation
at -40°C in a polyacrylamide gel containing 7 M urea. These
observations are consistent, however, with the formation of a
protease- and urea-insensitive protein * RNA complex. DNase I,
a Ca2+-metalloenzyme similar to micrococcal nuclease, is
protected from proteinase K digestion when complexed with
Ca2+ (29). Micrococcal nuclease is resistant to heat denaturation
when bound to Ca2+ or to denatured DNA (4). Thus, we might
expect micrococcal nuclease to be at least partially proteinase
K-resistant and denaturation-resistant when bound to RNA.
Artifactual Inhibition of RNA Processing by Inactive
Micrococcal Nuclease
Ryner and Manley (19) demonstrated that mRNA 3' cleavage
and polyadenylation activity could be restored to an MN-treated
extract of HeLa cell nuclei by adding carrier E. coli RNA. Their
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explanation was that the processing activities had a general
requirement for RNA mass. Other groups have observed similar
findings, and have sometimes attributed the inhibition to non-
specific RNA binding proteins released from endogenous RNA
by MN treatment. We offer a molecular explanation termed
substrate masking which we find is supported by direct
biochemical measurements. Micrococcal nuclease, from which
Ca2+ has been removed by chelation with EGTA, retains the
capacity to bind RNA tightly but reversibly. The sites for
processing on the RNA are thus occluded or masked and are
unavailable for enzymatic interaction. Addition of excess
competitive ligand, namely carrier RNA, displaces MN from
substrate RNA and allows normal RNA processing. If the protein
fraction to be tested for MN sensitivity contains significant
endogenous RNA, then substrate masking will be observed only
after hydrolysis of this RNA, i.e., only when MN is active during
the preincubation. Protein fractions lacking RNA will be subject
to substrate masking both by active as well as by inactive MN.
This phenomenon is documented in Figure lB. It is important
to choose a carrier RNA which does not inhibit the RNA
processing reaction under investigation. For example, RNase P
activities of chloroplasts, E. coli, wheat embryo, and yeast nuclei
are not inhibited by poly(A), but are strongly inhibited by poly(U)
and (at least for chloroplast and yeast RNase P) by heparin
(unpublished observationis). RNase P activity in HeLa cell
nuclear extracts, on the other hand, is strongly (> 95 %) inhibited
by all synthetic polynucleotides we have tested, and only slightly
less so by carrier yeast RNA (unpublished observations).
Previous experiments with nuclear RNase P indicated that its
activity was suppressed by treatment with MN (16,17). Our
results indicate that the yeast nuclear activity may not intrinsically
be sensitive to nuclease digestion. Eukaryotic nuclear RNase P
activities co-purify extensively with large RNA molecules, but
there is currently no independent evidence to indicate that these
RNAs are required for enzyme activity. We suggest that further
work is needed to clarify the relationship between micrococcal
nuclease inhibition and RNA function in nuclear RNase P. The
RNA component of nuclear RNase Ps might be bound to protein
in such a way as to be inaccessible to, or resistant to, nuclease
attack. The low buoyant density of these ribonucleoproteins is
also consistent with a model in which the RNA is sequestered
by protein, thus reducing its interaction with Cs+ ions. These
considerations, combined with our experimental evidence, argue
for careful experimental design when using micrococcal nuclease
in ribonucleoprotein analysis, and for caution in the interpretation
of such data.
ACKNOWLEDGMENTS
We thank Drs. Nancy Martin and Margaret Hollingsworth for
plasmid pAsp3 1, Dr. Olke Uhlenbeck for plasmid p67CFO, and
Xinqiang Li for labeled pre-tRNA used in initial filter binding
assays. Dr. R. H. Himes provided counsel on the interpretation
of binding results. Dr. G. van Tuyle pointed out the relationship
between Cs+ binding and RNA buoyant density. This work was
supported by grants from the NSF (DMB 86-09647) and the
University of Kansas General Research Fund (#3007) awarded
to PAG.
REFERENCES
2. Serpersu, E. H., Shortle, D., and Mildvan, A. S. (1987) Biochemistry 26,
1289-1300.
3. Shortle, D. (1983) Gene 22, 181-189.
4. Cuatrecasas, P., Fuchs, S., and Anfmsen, C. B. (1967) J. Biol. Chem. 242,
1541- 1547.
5. von Hippel, P. H. and Felsenfeld G. (1964) Biochemistry 3, 27-39.
6. Cotton, F. A., Hazen, E. E., Jr., and Legg, M. J. (1979) Proc. Natl. Acad.
Sci. USA 76, 2551-2555.
7. Stark, B.C., Kole, R., Bowman, E., and Altman, S. (1978) Proc. Natl. Acad.
Sci. USA 75, 3717-3721.
8. Hollingsworth, M. J. and Martin, N. C. (1986) Mol. Cell. Biol. 6, 1058-
1064.
9. Krupp, G., Cherayil, B., Frendewey, D., Nishikawa, S. and S611, D. (1986)
EMBO J. 5, 1697-1703.
10. Hashimoto, C. and Steitz, J. A. (1986) Cell 45, 581-591.
11. Mowry, K. L. and Steitz, J. A. (1987) Science 238, 1682-1687.
12. Pelham, H. R. B. and Jackson, R. J. (1976) Eur. J. Biochem. 67, 247-256.
13. Blanchard, J. S. (1984) Meth. Enz. 104, 404-414.
14. Doersen, C. J., Guerrier-Takada, C., Altman, S., and Attardi, G. (1985)
J. Biol. Chem. 260, 5942-5949.
15. Akaboshi, E., Guerrier-Takada, C., and Altman, S. (1980) Biochem. Biophys.
Res. Comm. 96, 831-837.
16. Kline, L., Nishikawa, S., and S611, D. (1981) J. Biol. Chem. 256, 5058- 5063.
17. Lee, J. Y. and Engelke, D. R. (1989) Mol. Cell. Biol. 9, 2536-2543.
18. Wang, M. J., Davis, N. W., and Gegenheimer, P. (1988) EMBO J. 7, 1567-
1574.
19. Ryner, L. C. and Manley, J. L. (1987) Mol. Cell. Biol. 7, 495-503.
20. McGhee, J. D. and von Hippel, P. H. (1974) J. Mol. Biol. 86, 469-489.
21. Parker, C.S. and Topol, J., unpublished protocol; cited in Ref. 27.
22. Dorn, A., Bollekens, J., Staub, A., Benoist, C., and Mathis, D. (1987) Cell
50, 863-872.
23. Faus, I., and Richardson, J. P. (1989) Biochemistry 28, 3510-3517.
24. Pace, N. R. and Smith, D. (1990) J. Biol. Chem. 265, 3587-3590.
25. Nichols, Soll D. and Willis, I. (1988) Proc. Natl. Acad. Sci. USA 85,
1379-1383.
26. Bartkiewicz, M., Gold, H., and Altman, S. (1989) Genes Dev. 3, 488-499.
27. Engelke, D. R., Gegenheimer, P. and Abelson, J. (1985) J. Biol. Chem.
260, 1271-1279.
28. Jaques, L. B. (1979) Science 206, 528-533.
29. Tullis, R. H. and Rubin, H. (1980) Anal. Biochem. 107, 260-264.
1. Anfinsen, C. B., Cuatrecasas, P., and Taniuchi, H. (1971) in Boyer, P. D.
(ed.), The Enzymes, 3rd ed. (New York: Academic Press) Vol. 4, pp.
177-204.
